Correlation Between MIRA Pharmaceuticals, and Emergent Biosolutions

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both MIRA Pharmaceuticals, and Emergent Biosolutions at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining MIRA Pharmaceuticals, and Emergent Biosolutions into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between MIRA Pharmaceuticals, Common and Emergent Biosolutions, you can compare the effects of market volatilities on MIRA Pharmaceuticals, and Emergent Biosolutions and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in MIRA Pharmaceuticals, with a short position of Emergent Biosolutions. Check out your portfolio center. Please also check ongoing floating volatility patterns of MIRA Pharmaceuticals, and Emergent Biosolutions.

Diversification Opportunities for MIRA Pharmaceuticals, and Emergent Biosolutions

0.29
  Correlation Coefficient

Modest diversification

The 3 months correlation between MIRA and Emergent is 0.29. Overlapping area represents the amount of risk that can be diversified away by holding MIRA Pharmaceuticals, Common and Emergent Biosolutions in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Emergent Biosolutions and MIRA Pharmaceuticals, is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on MIRA Pharmaceuticals, Common are associated (or correlated) with Emergent Biosolutions. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Emergent Biosolutions has no effect on the direction of MIRA Pharmaceuticals, i.e., MIRA Pharmaceuticals, and Emergent Biosolutions go up and down completely randomly.

Pair Corralation between MIRA Pharmaceuticals, and Emergent Biosolutions

Given the investment horizon of 90 days MIRA Pharmaceuticals, Common is expected to generate 1.72 times more return on investment than Emergent Biosolutions. However, MIRA Pharmaceuticals, is 1.72 times more volatile than Emergent Biosolutions. It trades about 0.18 of its potential returns per unit of risk. Emergent Biosolutions is currently generating about 0.3 per unit of risk. If you would invest  100.00  in MIRA Pharmaceuticals, Common on October 20, 2024 and sell it today you would earn a total of  21.00  from holding MIRA Pharmaceuticals, Common or generate 21.0% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthVery Weak
Accuracy100.0%
ValuesDaily Returns

MIRA Pharmaceuticals, Common  vs.  Emergent Biosolutions

 Performance 
       Timeline  
MIRA Pharmaceuticals, 

Risk-Adjusted Performance

5 of 100

 
Weak
 
Strong
Modest
Compared to the overall equity markets, risk-adjusted returns on investments in MIRA Pharmaceuticals, Common are ranked lower than 5 (%) of all global equities and portfolios over the last 90 days. Despite somewhat weak basic indicators, MIRA Pharmaceuticals, sustained solid returns over the last few months and may actually be approaching a breakup point.
Emergent Biosolutions 

Risk-Adjusted Performance

1 of 100

 
Weak
 
Strong
Weak
Compared to the overall equity markets, risk-adjusted returns on investments in Emergent Biosolutions are ranked lower than 1 (%) of all global equities and portfolios over the last 90 days. In spite of comparatively uncertain fundamental drivers, Emergent Biosolutions may actually be approaching a critical reversion point that can send shares even higher in February 2025.

MIRA Pharmaceuticals, and Emergent Biosolutions Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with MIRA Pharmaceuticals, and Emergent Biosolutions

The main advantage of trading using opposite MIRA Pharmaceuticals, and Emergent Biosolutions positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if MIRA Pharmaceuticals, position performs unexpectedly, Emergent Biosolutions can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Emergent Biosolutions will offset losses from the drop in Emergent Biosolutions' long position.
The idea behind MIRA Pharmaceuticals, Common and Emergent Biosolutions pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Fundamentals Comparison module to compare fundamentals across multiple equities to find investing opportunities.

Other Complementary Tools

Portfolio Diagnostics
Use generated alerts and portfolio events aggregator to diagnose current holdings
CEOs Directory
Screen CEOs from public companies around the world
Balance Of Power
Check stock momentum by analyzing Balance Of Power indicator and other technical ratios
Pattern Recognition
Use different Pattern Recognition models to time the market across multiple global exchanges
USA ETFs
Find actively traded Exchange Traded Funds (ETF) in USA